Insulin lispro Subcutaneous and Zoledronic acid
Determining the interaction of Insulin lispro Subcutaneous and Zoledronic acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin lispro Subcutaneous-Zoledronic Acid (Bone Health)
- Insulin lispro Subcutaneous-Zoledronic Acid (Zometa)
- Insulin lispro Subcutaneous-Zoledronic Acid Injection
- Insulin lispro Subcutaneous-Zoledronic Acid Injection Concentrate
- Insulin lispro Subcutaneous-Zoledronic acid Intravenous
- Insulin lispro Subcutaneous-Zoledronic Acid IV
- Zoledronic acid-Insulin NPH
- Zoledronic acid-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Zoledronic acid-Insulin NPH (Vials)
- Zoledronic acid-Insulin NPH and Insulin Regular
- Zoledronic acid-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Zoledronic acid-Insulin NPH and Insulin Regular (Vials)